METHOD FOR DISTINGUISHING AML SUBTYPES WITH ABERRANT AND PROGNOSTICALLY INTERMEDIATE KARYOTYPES

摘要

Disclosed is a method for distinguishing AML subtypes with aberrant and prognostically intermediate karyotypes selected from trisomy 8, inv(3), t(3;3), trisomy 11, trisomy 13, trisomy 4, t(1;3), t(6;9), der(5)t(5;11), i(17), del(9q), del(12p), and/or del(20q)in a sample by determining the expression level of markers, as well as a diagnostic kit and an apparatus containing the markers.